Breaking News Instant updates and real-time market news.

TSRO

Tesaro

$42.30

-4.62 (-9.85%)

18:01
06/04/18
06/04
18:01
06/04/18
18:01

Tesaro says Zejula data 'promising'

Tesaro summarized the results of the TOPACIO and QUADRA trials during an investor briefing held in conjunction with the 2018 American Society of Clinical Oncology Annual Meeting. "The promising data presented at this year's ASCO meeting demonstrated the potential of ZEJULA not only as a monotherapy treatment for women with advanced ovarian cancer, but also in combination with an anti-PD-1 antibody, to provide a meaningful clinical benefit to patients beyond those with BRCA mutations," said Mary Lynne Hedley, Ph.D., President and COO of TESARO. "Our oncology development strategy is focused on rational therapeutic combinations and niraparib and TSR-042, our anti-PD-1 antibody, are the foundation of this strategy. The TOPACIO results support the advancement of combination studies in ovarian cancer and breast cancers and we have initiated preparations for registrational trials of niraparib in combination with TSR-042 in these settings. QUADRA results demonstrated that ZEJULA is active as a late-line treatment for patients beyond those with BRCA mutations, which is the only treatment setting in which PARP inhibitors are approved today, and we intend to submit an sNDA in the fourth quarter of 2018."

  • 04

    Jun

TSRO Tesaro
$42.30

-4.62 (-9.85%)

05/03/18
PIPR
05/03/18
NO CHANGE
Target $50
PIPR
Neutral
Tesaro price target lowered to $50 from $60 at Piper Jaffray
Piper Jaffray analyst Christopher Raymond lowered his price target on Tesaro to $50, saying that while Q1 results were "solid" thanks to a Zejula beat, the limited visibility around the geographic mic and below-consensus outlook for Q2 will keep shares under pressure. The analyst kept his Neutral rating on Tesaro, adding that the increasing interchangeability of the marketed PARP inhibitors and a potential safety disadvantage for Zejula could further drag on the uptake, pressuring FY18 guidance.
05/07/18
LSCM
05/07/18
NO CHANGE
Target $80
LSCM
Buy
Tesaro price target lowered to $80 from $120 at Lake Street
Lake Street analyst Bruce Jackson lowered his price target for Tesaro to $80 saying the company reported "disappointing" Q1 results. The analyst was hoping for more of a rebound in Zejula growth but notes the "tepid" Q2 revenue guide "suggests otherwise. He lowered his 2018 revenue estimate to $279M from $322M but keeps a Buy rating on Tesaro shares.
05/30/18
JEFF
05/30/18
NO CHANGE
Target $48
JEFF
Hold
Tesaro risk/reward 'skewed toward downside,' says Jefferies
Jefferies analyst Eun Yang believes Tesaro's (TSRO) risk/reward is "skewed toward downside" into AstraZeneca's (AZN) Phase 3 ovarian cancer data for Lynparza . A discussion with a key opinion leader points to high bar for clinical/commercial success, Yang tells investors in a research note. She points out that Zejula in first-line ovarian cancer accounts for greater than 40% of her $48 price target for Tesaro. The analyst keeps a Hold rating on the shares.
05/31/18
SBSH
05/31/18
NO CHANGE
Target $100
SBSH
Buy
Amid investor questions, Citi reiterates $100 target on Tesaro
Citi analyst Robyn Karnauskas says she's been getting a lot of investor questions on Tesaro (TSRO) around the impact of Avastin approval on PARP use in first-line ovarian cancer, ahead of AstraZeneca's (AZN) Solo-1 data expected in the first half of 2018. After speaking to Tesaro's CEO, the analyst continues to be constructive on the quarter. The company believes that eventually Avastin will mostly be used in combinations, Karnauskas tells investors in a research note. She thinks Tesaro shares "will emerge" with crucial data expected in the latter half of the year. The analyst reiterates a Buy rating on the shares with a $100 price target.

TODAY'S FREE FLY STORIES

02:50
10/18/18
10/18
02:50
10/18/18
02:50
General news
FX Update: The Dollar has traded mostly firmer »

FX Update: The Dollar has…

01:45
10/18/18
10/18
01:45
10/18/18
01:45
General news
Asian Market Wrap: »

Asian Market Wrap:…

01:45
10/18/18
10/18
01:45
10/18/18
01:45
General news
Breaking General news story  »

8-Week Bill Settlement to…

23:10
10/17/18
10/17
23:10
10/17/18
23:10
General news
Asia Market Action: equities are mixed »

Asia Market Action:…

PHAS

PhaseBio

$0.00

(0.00%)

21:06
10/17/18
10/17
21:06
10/17/18
21:06
Syndicate
PhaseBio 9.2M share IPO priced at $5.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

MSC

Studio City

$0.00

(0.00%)

21:00
10/17/18
10/17
21:00
10/17/18
21:00
Syndicate
Studio City 28.75M share IPO priced at $12.50 »

The deal was priced at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

BHGE

Baker Hughes

$30.75

-0.09 (-0.29%)

, CJ

C&J Energy Services

$20.40

-0.12 (-0.58%)

20:38
10/17/18
10/17
20:38
10/17/18
20:38
Recommendations
Baker Hughes, C&J Energy Services, FTS International, Halliburton, Keane Group, Nabors Industries, Nine Energy Services, Patterson-UTI, ProPetro Holding, Schlumberger, Covia , Helmerich & Payne, U.S. Silica, Weatherford analyst commentary at BofA/Merrill »

BofA/Merrill reinstating…

BHGE

Baker Hughes

$30.75

-0.09 (-0.29%)

CJ

C&J Energy Services

$20.40

-0.12 (-0.58%)

FTSI

FTS International

$12.87

-0.115 (-0.89%)

HAL

Halliburton

$39.56

-0.52 (-1.30%)

FRAC

Keane Group

$12.50

-0.14 (-1.11%)

NBR

Nabors Industries

$6.25

-0.175 (-2.72%)

NINE

Nine Energy Services

$39.10

0.31 (0.80%)

PTEN

Patterson-UTI

$16.58

-0.37 (-2.18%)

PUMP

ProPetro Holding

$18.19

-0.315 (-1.70%)

SLB

Schlumberger

$59.24

-0.43 (-0.72%)

CVIA

Covia

$7.01

-0.57 (-7.52%)

HP

Helmerich & Payne

$68.06

-1.13 (-1.63%)

SLCA

U.S. Silica

$17.69

-1.03 (-5.50%)

WFT

Weatherford

$2.61

-0.03 (-1.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 29

    Oct

  • 30

    Oct

  • 30

    Oct

  • 01

    Nov

  • 01

    Nov

PM

Philip Morris

$84.62

1.12 (1.34%)

, DHR

Danaher

$104.95

-0.13 (-0.12%)

20:25
10/17/18
10/17
20:25
10/17/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PM

Philip Morris

$84.62

1.12 (1.34%)

DHR

Danaher

$104.95

-0.13 (-0.12%)

BK

BNY Mellon

$49.16

-0.17 (-0.34%)

NVS

Novartis

$85.34

-0.41 (-0.48%)

BX

Blackstone

$36.06

-0.02 (-0.06%)

BBT

BB&T

$47.73

0.64 (1.36%)

TRV

Travelers

$126.47

1.75 (1.40%)

PPG

PPG

$98.15

-0.06 (-0.06%)

KEY

KeyCorp

$18.75

0.17 (0.91%)

NUE

Nucor

$59.11

0.17 (0.29%)

TXT

Textron

$64.72

-2.01 (-3.01%)

GPC

Genuine Parts

$95.26

-1.83 (-1.88%)

DOV

Dover

$82.28

-0.95 (-1.14%)

WBC

Wabco

$103.09

-6.91 (-6.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 18

    Oct

  • 19

    Oct

  • 19

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 16

    Nov

  • 13

    Dec

  • 18

    Oct

AVMXY

Avita Medical

$0.00

(0.00%)

19:55
10/17/18
10/17
19:55
10/17/18
19:55
Hot Stocks
Avita Medical announces first U.S. sales of Recell system »

AVITA Medical announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FRAC

Keane Group

$12.50

-0.14 (-1.11%)

19:33
10/17/18
10/17
19:33
10/17/18
19:33
Initiation
Keane Group initiated at BofA/Merrill »

Keane Group initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

NBR

Nabors Industries

$6.25

-0.175 (-2.72%)

19:28
10/17/18
10/17
19:28
10/17/18
19:28
Initiation
Nabors Industries initiated at BofA/Merrill »

Nabors Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

NINE

Nine Energy Services

$39.10

0.31 (0.80%)

19:19
10/17/18
10/17
19:19
10/17/18
19:19
Initiation
Nine Energy Services initiated at BofA/Merrill »

Nine Energy Services…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

PTEN

Patterson-UTI

$16.58

-0.37 (-2.18%)

19:17
10/17/18
10/17
19:17
10/17/18
19:17
Initiation
Patterson-UTI initiated at BofA/Merrill »

Patterson-UTI initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

GSBC

Great Southern Bancorp

$52.51

0.26 (0.50%)

19:04
10/17/18
10/17
19:04
10/17/18
19:04
Earnings
Great Southern Bancorp reports preliminary Q3 EPS $1.18, consensus $1.06 »

Reports Q3 NI $43.0M vs.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 24

    Oct

HMNY

Helios and Matheson

$0.02

0.001 (5.18%)

18:59
10/17/18
10/17
18:59
10/17/18
18:59
Periodicals
Breaking Periodicals news story on Helios and Matheson »

Helios & Matheson…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BY

Byline Bancorp

$21.33

0.02 (0.09%)

18:51
10/17/18
10/17
18:51
10/17/18
18:51
Hot Stocks
Byline Bancorp to acquire Oak Park River Forest Bankshares for $42M »

Byline Bancorp and Oak…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

ABB

ABB

$21.37

-0.115 (-0.54%)

18:48
10/17/18
10/17
18:48
10/17/18
18:48
Periodicals
ABB weighs divesting $10B power grid business, Bloomberg reports »

ABB is working with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VEC

Vectrus

$28.98

-0.74 (-2.49%)

18:22
10/17/18
10/17
18:22
10/17/18
18:22
Hot Stocks
Vectrus names Kevin Boyle chief legal officer »

Vectrus announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

S

Sprint

$6.41

-0.005 (-0.08%)

18:21
10/17/18
10/17
18:21
10/17/18
18:21
Hot Stocks
Sprint extends credits to Florida customers impacted by Hurricane Michael »

Sprint said it continues…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

TALO

Talos Energy

$29.85

-1.49 (-4.75%)

18:05
10/17/18
10/17
18:05
10/17/18
18:05
Hot Stocks
Talos Energy reaches pact with Hokchi to cross-assign interests »

Talos Energy Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

STLD

Steel Dynamics

$40.55

0.29 (0.72%)

18:05
10/17/18
10/17
18:05
10/17/18
18:05
Hot Stocks
Steel Dynamics CEO says 'delivered a tremendous third quarter performance' »

"The team delivered…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

STLD

Steel Dynamics

$40.55

0.29 (0.72%)

18:02
10/17/18
10/17
18:02
10/17/18
18:02
Hot Stocks
Steel Dynamics CEO: We believe steel consumption will continue to be strong »

"We remain confident…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

STLD

Steel Dynamics

$40.55

0.29 (0.72%)

18:01
10/17/18
10/17
18:01
10/17/18
18:01
Earnings
Steel Dynamics reports Q3 adjusted EPS $1.69, consensus $1.64 »

Reports Q3 revenue $3.2B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

CRTO

Criteo

$23.00

-0.29 (-1.25%)

, RUBI

Rubicon Project

$3.77

-0.06 (-1.57%)

17:44
10/17/18
10/17
17:44
10/17/18
17:44
Periodicals
Advertising technology firm DataXu exploring sale, WSJ says »

DataXu, which offers…

CRTO

Criteo

$23.00

-0.29 (-1.25%)

RUBI

Rubicon Project

$3.77

-0.06 (-1.57%)

FUEL

Rocket Fuel

$0.00

(0.00%)

GOOG

Alphabet

$1,115.99

-4.12 (-0.37%)

FB

Facebook

$159.46

0.65 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 25

    Oct

  • 28

    Oct

  • 30

    Oct

  • 07

    Nov

  • 07

    Nov

  • 15

    Nov

  • 16

    Nov

  • 03

    Mar

BTU

Peabody Energy

$36.09

-0.31 (-0.85%)

17:37
10/17/18
10/17
17:37
10/17/18
17:37
Hot Stocks
Peabody Energy increases quarterly dividend nearly 4% to 13c per share »

Peabody Energy announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.